Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00970008
Other study ID # R01AT004623-01
Secondary ID
Status Completed
Phase Phase 2
First received August 18, 2009
Last updated May 1, 2015
Start date September 2009
Est. completion date August 2011

Study information

Verified date April 2015
Source Rutgers, The State University of New Jersey
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

In 2004, we conducted a pilot randomized, wait list controlled, trial (RCT) of massage therapy for OA of the knee in 68 subjects. That study, supported by CDC grant SIP-14-00, revealed the potential efficacy of Swedish massage therapy in the treatment of OA of the knee, with benefits of increased function and decreased pain persisting at least eight weeks following treatment cessation. The results of that trial, the first RCT of massage for OA, were published in the Archives of Internal Medicine in 2006 (See reference in More Information section). This current project builds on the design and findings of the pilot trial to determine the optimal dose and treatment regimen and provide longer term follow up. This project is a dual-site, randomized, dose-ranging trial to compare four dose/regimens in order to identify the optimal protocol for clinical practice.

The primary study hypothesis is that an eight (8) week course of Swedish massage therapy of one of the four proposed doses (by frequency and duration of massage treatment session) will be effective in reducing pain and improving function in patients with confirmed OA of the knee.


Description:

A dual-site, randomized, dose-ranging trial to determine the role and practice parameters for massage in the standard clinical management of OA based on investigation of efficacy and mechanism of action. The study hypothesis is that an 8 week course of Swedish massage therapy will be effective in reducing pain and improving function in patients with confirmed OA of the knee. A future phase III trial is planned to test the optimal massage intervention identified in this study against a validated sham/control intervention, incorporating all pertinent outcome measures from the antecedent studies. In addition, this study will further the development of robust methodologies to test the efficacy of massage interventions in general. The research agenda advanced by the current study will culminate with the establishment of the proper place for massage therapy among standard treatment options for the millions of Americans suffering with osteoarthritis.


Recruitment information / eligibility

Status Completed
Enrollment 125
Est. completion date August 2011
Est. primary completion date July 2011
Accepts healthy volunteers No
Gender Both
Age group 35 Years and older
Eligibility Inclusion Criteria:

- 35 years of age or greater.

- Written confirmation of OA of the knee as provided by the participant's physician.

- Radiographically-established OA of the knee.

- Pre-randomization score of 40 to 90 on the Visual Analog Pain Scale (0-100 mm scale).

- Patients with bilateral knee involvement will have the more severely affected knee designated as the study knee.

- American College of Rheumatology defined OA of the knee:

1. Knee pain

2. Satisfaction of at least five of the following nine criteria:

1. Age greater than 50 years

2. Stiffness < 30 minutes

3. Crepitus

4. Bony tenderness

5. Bony enlargement

6. No palpable warmth

7. ESR < 40 mm/hr

8. Rheumatoid Factor (RF) < 1:40

Exclusion Criteria: (no exclusion criterion may be present)

- Presence of rheumatoid arthritis, fibromyalgia, recurrent or active pseudo gout.

- Presence of cancer or other serious medical conditions.

- Signs or history of kidney or liver failure.

- Presence of asthma requiring the use of corticosteroid treatment.

- Use of oral corticosteroids within the past four weeks.

- Use of intra-articular knee depo-corticosteroids with the past three months.

- Use of intra-articular hyaluronate with the past six months.

- Arthroscopic surgery of the knee within the past year.

- Significant injury to the knee within the past six months.

- Presence of a rash or open wound over the knee.

- Unable to satisfy the treatment and follow-up requirements.

- Unable to provide written informed consent.

- Currently receiving massage therapy on a regular basis (at least twice a month).

- Knee replacement of study knee (ok if the knee not being studied has been replaced).

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Intervention

Other:
Massage 30 min 2x/wk x4 wks then 1x/wk x4 wks
Swedish massage session of 30 minutes duration, twice weekly for four weeks followed by once weekly for four weeks over a eight (8) week period. Total intervention = 12 sessions for 360 minutes.
Massage 60 min 2x/wk for 4 wks then 1x/wk for 4 wks
Swedish massage session of 60 minutes duration, twice weekly for four weeks followed by once weekly for four weeks over a eight (8) week period. Total intervention = 12 sessions for 720 minutes.
Massage 30 min sessions 1x/wk for 8 wks
Swedish massage session of 30 minutes duration, once weekly for eight weeks over a eight (8) week period. Total intervention = 8 sessions for 240 minutes.
Massage 60 min session 1x/wk for 8 wks
Swedish massage session of 60 minutes duration, once weekly for eight weeks over a eight (8) week period. Total intervention = 8 sessions for 480 minutes

Locations

Country Name City State
United States Yale-Griffin Prevention Research Center/Griffin Hospital Derby Connecticut
United States Siegler Center for Integrative Medicine - Saint Barnabas Ambulatory Care Center Livingston New Jersey

Sponsors (2)

Lead Sponsor Collaborator
University of Medicine and Dentistry of New Jersey Yale University

Country where clinical trial is conducted

United States, 

References & Publications (1)

Perlman AI, Sabina A, Williams AL, Njike VY, Katz DL. Massage therapy for osteoarthritis of the knee: a randomized controlled trial. Arch Intern Med. 2006 Dec 11-25;166(22):2533-8. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Improvement in WOMAC (Western Ontario Multipurpose Arthritis Centers) Knee and Hip Osteoarthritis Index Six (6) months No
Secondary Safety Six (6) months Yes
Secondary Improvement in range of motion as measured by a goniometer. six (6) months No
Secondary Improvement in physical function as measured by time in seconds to walk fifty (50) feet on a level straight surface. six (6) months No
Secondary Reduction in pain as measured by the Visual Analog Scale (VAS) for pain. Six (6) months No
See also
  Status Clinical Trial Phase
Completed NCT03277066 - A 4-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Knee Osteoarthritis Phase 2
Recruiting NCT03090698 - Outcomes of Injections in Patients Waiting for Total Knee Replacement Phase 4
Completed NCT02556710 - A Study to Evaluate the Efficacy & Safety of an Intra-Articular Ampion Injection for Pain of Osteoarthritis of the Knee Phase 3
Withdrawn NCT02237846 - Clinical Study of Umbilical Cord Tissue Mesenchymal Stem Cells (UC-MSC) for Treatment of Osteoarthritis Phase 1/Phase 2
Completed NCT02242435 - A Multiple Injection Study Evaluating Safety and Efficacy of Ampion in Osteoarthritis Phase 3
Completed NCT02096393 - Patient Specific Instrumentation in TKR N/A
Completed NCT01849445 - Targeted Rehabilitation to Improve Outcome After Knee Replacement- A Physiotherapy Study N/A
Completed NCT01704157 - A Prospective Study Evaluating the Treatment of Knee Osteoarthritis With the Cryo-Touch III Device N/A
Active, not recruiting NCT01374230 - Long-Term Multicenter Evaluation of the E1® Tibial Bearing N/A
Not yet recruiting NCT01270412 - Platelet Rich Plasma (PRP) as a Treatment for Knee Osteoarthritis PRP as a Treatment for Knee Osteoarthritis Phase 2/Phase 3
Completed NCT02156440 - Cross-over Study of the Efficacy and Safety of SierraSil Joint Formula 14 in Osteoarthritis of the Knee Phase 2
Completed NCT01410409 - Structured Treatment of Osteoarthritis of the Knee With or Without Total Knee Replacement N/A
Completed NCT01207115 - A Study of ABT-652 in Adults With Osteoarthritis Pain of the Knee Phase 2
Completed NCT01331278 - A Comparative Study of Knee Systems Phase 4
Completed NCT00988091 - Investigation of 1.2% Sodium Hyaluronate for Treatment of Painful Chronic Osteoarthritis of the Knee Phase 3
Completed NCT00792727 - HKT-500 in Adult Patients With Osteoarthritis (OA) Knee Pain Phase 3
Completed NCT00531427 - Buprenorphine Transdermal System (BTDS) in Subjects w/Mod-sev Osteoarthritis (OA) Chronic Pain of Knee Phase 3
Completed NCT00449696 - Gel-200 Versus Placebo in Osteoarthritis of the Knee Phase 3
Completed NCT04145011 - Coolief Cooled Radiofrequency vs. Conventional Radiofrequency to Manage OA Knee Pain N/A
Completed NCT01430559 - Effect Of Meloxicam Versus Placebo In Mainland Chinese Patients With Osteoarthritis Of The Knee N/A